Patients affected with wet AMD are one step closer to real hope for vision improvement Charlottetown PE

Canadians living with wet age-related macular degeneration (AMD) will be pleased to know the Common Drug Review (CDR), Canada's national drug review ...

RBC - 335 University Ave Br
(902) 892-0104
335 University Ave
Charlottetown, PE
Languages
English, French
Office Hours
Monday: 10:00 - 17:00
Tuesday: 10:00 - 17:00
Wednesday: 10:00 - 17:00
Thursday: 10:00 - 17:00
Friday: 10:00 - 17:00
Saturday: Closed
Sunday: Closed

BMO Bank of Montreal
(902) 894-7021
670 University Ave
Charlottetown, PE
Type
Branch with ABM

RBC - Charlottetown Branch
(902) 892-2405
83 Queen St
Charlottetown, PE
Languages
English, French
Office Hours
Monday: 10:00 - 17:00
Tuesday: 10:00 - 17:00
Wednesday: 10:00 - 17:00
Thursday: 10:00 - 17:00
Friday: 10:00 - 17:00
Saturday: Closed
Sunday: Closed

RBC - Summerside Branch (New Location!)
(902) 436-4237
222 Water St-Po Box 1656
Summerside, PE
Languages
English, French
Office Hours
Monday: 10:00 - 17:00
Tuesday: 10:00 - 17:00
Wednesday: 10:00 - 17:00
Thursday: 10:00 - 17:00
Friday: 10:00 - 17:00
Saturday: Closed
Sunday: Closed

Scotiabank
(902) 859-2310
494 Main Street
Oleary, PE
 
Scotiabank
(902) 894-5013
135 St. Peters Road
Charlottetown, PE
 
BMO Bank of Montreal
(902) 892-2437
105 Grafton St
Charlottetown, PE
Type
Branch with ABM

Scotiabank
(902) 566-5004
143 Grafton Street
Charlottetown, PE
 
Scotiabank
(902) 838-2252
552 Main Street
Montague, PE
 
Scotiabank
(902) 855-2233
Trans Canada Hwy 1A, Road 115
Albany, PE
 

Patients affected with wet AMD are one step closer to real hope for vision improvement

Provided By:

(NC)-Canadians living with wet age-related macular degeneration (AMD) will be pleased to know the Common Drug Review (CDR), Canada's national drug review process, which is in charge of providing recommendations on which drugs should be covered under provincial drug plans, has recently announced that Lucentis should be added to the list of medications paid for by each province.

Until now, available treatments were only able to slow the progression of the disease. Lucentis is the first and only approved treatment to improve vision in some patients. Wet AMD is a progressive disease that attacks the central vision of the eye, necessary for ordinary vision-related activities such as seeing faces, reading and driving. This decision gives real hope for vision improvement for these patients for whom the diagnosis of wet AMD could previously have meant severe central vision loss and possibly even blindness in a matter of weeks to months.

Andy Livingstone noticed remarkable results after only three injections of Lucentis. Small actions he took for granted had become impossible for him. With this new treatment, he can now slice cheese, do the washing and recognize people in the streets. He even took care of his wife after she had brain surgery, something he would not have been able to do before he started the treatment. Andy has gained back his independence.

"You can't put a price on regaining your vision and your quality of life", says Andy. "Mine has improved so much thanks to this unique treatment, I can't even put it into words."

In June, Health Canada approved the medication to treat the disease and restore some vision loss. Ontario and Quebec have decided to fight against blindness by already adding Lucentis to their provincial drug plans. It is now up to other individual provinces and territories to make the final listing and coverage decisions.

If you have been diagnosed with wet AMD or you notice a sudden change in your vision such as blurring or a blank spot in your visual field, speak to your eye doctor about this new advance in the treatment of wet AMD. Early diagnosis gives you a better chance at preserving your vision.

Credit: www.newscanada.com